期刊文献+

腹部间质瘤的诊断和治疗 被引量:1

原文传递
导出
摘要 目的探讨腹部间质瘤(abdominal stromal tumors,AST)的临床病理特点及诊治方法。方法对40例AST患者的临床资料进行回顾性分析。结果40例AST患者发生部位以胃(18例,45.0%)和小肠(8例,20.0%)为主。主要临床表现为腹痛、腹胀(29例,72.5%),消化道出血(13例,32.5%),腹部包块(12例,30.0%)和消化道梗阻(10例,25.0%)。免疫组化CD117阳性37例(92.5%),CD34阳性33例(82.5%),同时表达CD117和CD34者30例(75.0%),无CD117与CD34均阴性者。全部患者均行手术治疗。结论AST是消化道最常见的间叶源性肿瘤。CD117和CD34阳性可作为AST的诊断标准。外科手术与分子靶向药物的结合将是GIST的主要治疗模式。
出处 《中国普通外科杂志》 CAS CSCD 北大核心 2009年第4期424-426,共3页 China Journal of General Surgery
  • 相关文献

参考文献8

  • 1Miettinen M, Lasota J. Gastrointestinal stromal tamors-definition, clinical, histological, immu-nohistochemical, and mo lecular genetic features and differential diagnosis [ J ]. Virchows Arch ,2001,438 ( 1 ) : 1 - 12.
  • 2Schubert ML, Moghimi R. Gastrointestinal stromal tunor (GIST) [ J ]. Curr Treat Options Gastroenterol, 2006, 9 (2):181 -188.
  • 3伍晓汀,夏霖.胃肠道间质瘤的临床诊断和分期[J].中国实用外科杂志,2006,26(8):572-574. 被引量:37
  • 4叶颖江,王志强,王杉.胃肠间质瘤诊断和治疗进展[J].中华胃肠外科杂志,2007,10(1):91-94. 被引量:25
  • 5Miettinen M, Furlong M, Sarlomo-Rikala M, et al. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus [ J ]. Am J Surg Pathol, 2001,25(9) :1121 -1133.
  • 6万德森,伍小军,梁小曼,罗容珍,潘志忠,陈功,卢震海,丁培荣.胃肠道间质瘤的外科治疗[J].中华胃肠外科杂志,2003,6(5):288-291. 被引量:48
  • 7Pierie JP, Choudry U, Muizikansky A, et al. The effect of surgery and grade on outcome of gastrointestinal stromal tumors [J]. Arch Surg, 2001 ,136(4) :383 -389.
  • 8Demetri GD, von Mehren M, Blanke CD,et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors[J].N Engl J Med, 2002,347(7) :472 -480.

二级参考文献23

  • 1黄文斌,陈洁宇,周晓军.PKCθ:一个新的诊断胃肠道间质肿瘤(GIST),特别是KIT阴性表达的GIST的免疫组化标记物[J].临床与实验病理学杂志,2005,21(4):441-441. 被引量:20
  • 2贺慧颖,方伟岗,钟镐镐,李燕,郑杰,杜娟,衡万杰,吴秉铨.165例胃肠道间质瘤中c-kit和PDGFRA基因突变的检测和临床诊断意义[J].中华病理学杂志,2006,35(5):262-266. 被引量:73
  • 3詹文华,王鹏志,邵永孚,伍晓汀,顾晋,李荣,万德森,丁克峰,师英强,于吉人,卢辉山,邹小明,毕建威,孙益红,陆云飞,陈道达,张信华.伊马替尼术后辅助治疗胃肠间质瘤的多中心前瞻性临床试验中期报告[J].中华胃肠外科杂志,2006,9(5):383-387. 被引量:85
  • 4Mazur MT,Clark HB.Gastric stromal tumors:reappraisal of histogenesis. Am J Surg Pathol, 1983, 7: 507-519.
  • 5Meittinen M, Lasola J. Gastrointestinal stromal tumors-definition,clinical, histological, immunohistochemical, and differential diagnosis. Virchows Arch, 2001, 438: 1-12.
  • 6DeMatteo R, Lewis JJ, Leung D, et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg, 2000, 231: 51-58.
  • 7Ng EH, Pollock RE, Munsell MF, et al. Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Ann Surg,1992,215: 68-77.
  • 8Crosby JA, Catton LN, Davis A, et al. Malignant gastrointestinal stromal tumors of the small intestine: a review of 50 cases from a prospective database. Ann Surg Oncol, 2001, 8: 50-59.
  • 9Taniguchi N, Nishida T, Hirota S, et al. Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors. Cancer Bes, 1999, 59:4297-4300.
  • 10Clary BM, DeMatteo BP, Lewis ,I,I, et al. Gastrointestinal stromal tumors and leiomyosarcoma of the abdomen and restroperitomeum:a clinical comparison. Ann Surg Oneol, 2001, 8: 290-299.

共引文献107

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部